STOCK TITAN
  1. Home
  2. Sec-filings
  3. GEHC
  4. [Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

GE HealthCare (NASDAQ: GEHC) director granted 3,586 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lobo Kevin reported acquisition or exercise transactions in this Form 4 filing.

GE HealthCare Technologies Inc. director Kevin Lobo reported an equity award of restricted stock units covering 3,586 shares of common stock. The award represents a grant, not an open-market purchase, and increased his direct holdings to 4,363 shares.

The filing notes that 100% of these restricted stock units will vest on the earlier of the company’s next annual meeting of stockholders or May 7, 2027. Each unit delivers one share of GE HealthCare common stock at settlement, and settlement may be deferred under the company’s Non-Employee Director Compensation and Benefits Plan.

Positive

  • None.

Negative

  • None.
Insider Lobo Kevin
Role null
Type Security Shares Price Value
Grant/Award Common Stock, par value $0.01 per share 3,586 $0.00 --
Holdings After Transaction: Common Stock, par value $0.01 per share — 4,363 shares (Direct, null)
Footnotes (1)
  1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
RSU grant size 3,586 restricted stock units Award of GE HealthCare common stock units to director Kevin Lobo
Shares after award 4,363 shares Total direct holdings following the RSU grant
Vesting date latest May 7, 2027 Full vesting occurs by this date if not earlier at the next annual meeting
Vesting schedule 100% cliff vest All RSUs vest at once on earlier of next annual meeting or May 7, 2027
Award price per share $0.00 per share Compensation grant with no cash paid by the director
restricted stock units financial
"Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting financial
"100% will vest on the earlier of the date of GE HealthCare's next annual meeting of stockholders and May 7, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
settlement financial
"Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock"
Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.
Non-Employee Director Compensation and Benefits Plan financial
"in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lobo Kevin
(Last)(First)(Middle)
500 WEST MONROE STREET
(Street)
CHICAGO ILLINOIS 60661
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share05/07/2026A3,586(1)(2)A$04,363D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did GEHC director Kevin Lobo report?

Kevin Lobo reported receiving 3,586 restricted stock units in GE HealthCare common stock. This is a grant as board compensation, not an open-market share purchase, and it increased his direct holdings to 4,363 shares after the award.

How many GEHC shares does Kevin Lobo hold after this Form 4?

After the reported award, Kevin Lobo holds 4,363 shares of GE HealthCare common stock directly. This total reflects his prior holdings plus the 3,586 restricted stock units granted, each of which represents one share upon settlement.

When do Kevin Lobo’s GEHC restricted stock units vest?

All 3,586 restricted stock units vest 100% on the earlier of GE HealthCare’s next annual stockholder meeting or May 7, 2027. This time-based vesting schedule is typical for non-employee director compensation awards tied to continued board service.

What does each GEHC restricted stock unit granted to Kevin Lobo represent?

Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement. Once the vesting conditions are met and any deferral elections are satisfied, the company delivers the corresponding number of common shares.

Can Kevin Lobo defer settlement of his GEHC restricted stock units?

Yes. Settlement of vested restricted stock units may be deferred under GE HealthCare’s Non-Employee Director Compensation and Benefits Plan. In that case, payout timing follows his applicable deferral election, rather than occurring immediately upon vesting.